White Papers for Food and Drug Administration (FDA)

MKS Case Study TEVA

TEVA USA is a wholly-owned subsidiary of TEVA Pharmaceutical Industries Ltd., Israel's largest pharmaceutical manufacturer operating globally in 30 countries on 5 continents with 2004 sales of US$4.8 billion. The goal for TEVA is to reduce the burden and cost associated with compliance to FDA regulations. In 2003 TEVA's IT department identified requirements for a change control process that is more efficient and compliant with Good Manufacturing Processes (GMP). Following a thorough evaluation process, MKS Integrity Manager and MKS Source Integrity Enterprise, key components of the MKS Integrity Suite, were selected.

View the White Paper

Share or bookmarklet this web page at: